Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Barranco de La Ballena S/N, 35019, Las Palmas de Gran Canaria, Spain.
Department of Neurology, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain.
BMC Cardiovasc Disord. 2022 Mar 21;22(1):118. doi: 10.1186/s12872-021-02421-8.
Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance evaluated.
This is a single-center observational study evaluating 187 consecutively hospitalized patients with IS. EPCs were isolated from blood samples. The number of circulating angiogenic cells (CACs), colony-forming units (CFU-ECs) and the emergence of late outgrowths endothelial cells (LOECs) were counted. We collected clinical variables and measured the stromal cell-derived factor 1 alpha (SDF1α) serum levels. We also examined the relative telomere length and the expression of osteogenic gene markers in CACs.
CACs counts and CFU-ECs colony numbers were positively correlated (rho = 0.41, p < 0.001, n = 187). We found significant differences according to whether thrombolytic treatment was performed in the distribution of CFU-ECs (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.01-6.35; p = 0.042) and CACs (OR = 4.45; 95% IC 1.2-15.5; p = 0.012). The main determinants of CACs variation were the number of risks factors, thrombolysis treatment, arterial hypertension, LOECs occurrence, and the vascular endothelial growth factor expression, whereas CFU-ECs variations depended on hemoglobin content and the relative reduction in the National Institutes of Health Stroke Scale (NIHSS) criteria. The main predictors of LOECs appearance were thrombolysis and length of hospital stay.
Our study supports the relevance of patient risk factors and treatments in the analysis of the functional properties of EPCs.
内皮祖细胞(EPCs)是具有血管生成能力的循环细胞,与中风风险相关。我们旨在深入研究其功能特征。从缺血性中风(IS)患者中分离和培养 EPCs,并评估其变化的预测因素。
这是一项单中心观察性研究,评估了 187 例连续住院的 IS 患者。从血液样本中分离出 EPCs。计算循环血管生成细胞(CACs)、集落形成单位(CFU-ECs)和晚期生长内皮细胞(LOECs)的数量。我们收集了临床变量并测量了基质细胞衍生因子 1α(SDF1α)的血清水平。我们还检查了 CACs 中的相对端粒长度和成骨基因标志物的表达。
CACs 计数和 CFU-ECs 集落数量呈正相关(rho=0.41,p<0.001,n=187)。我们发现 CFU-ECs 的分布与溶栓治疗之间存在显著差异(比值比(OR)=2.5;95%置信区间(CI)1.01-6.35;p=0.042)和 CACs(OR=4.45;95%CI 1.2-15.5;p=0.012)。CACs 变化的主要决定因素是危险因素的数量、溶栓治疗、动脉高血压、LOECs 的发生以及血管内皮生长因子的表达,而 CFU-ECs 的变化取决于血红蛋白含量和国立卫生研究院卒中量表(NIHSS)标准的相对降低。LOECs 出现的主要预测因素是溶栓治疗和住院时间。
我们的研究支持患者风险因素和治疗方法在分析 EPCs 功能特性中的相关性。